Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd R Burmester

Showing results (41-50 of 334) with videos related to

Pageof 34
Sort By:
Journal of Autoimmunity|January 26, 2020
The etiology of rheumatoid arthritisHans Ulrich Scherer, Thomas Häupl, Gerd R Burmester
Rheumatology (Oxford, England)|February 21, 2025
Rheumatoid factors revisited in the age of biologic therapyAli Berkant Avci, Eugen Feist, Gerd R Burmester
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 22, 2023
Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What Have We Learned?Ali Berkant Avci, Eugen Feist, Gerd R Burmester
RMD Open|November 5, 2015
Biologicals in rheumatoid arthritis: current and futureAli Berkant Avci, Eugen Feist, Gerd-R Burmester
Annals of the Rheumatic Diseases|June 25, 2021
Successful BNT162b2 booster vaccinations in a patient with rheumatoid arthritis and initially negative antibody responseFredrik N Albach, Gerd R Burmester, Robert Biesen
Arthritis Research & Therapy|January 18, 2011
Kitasato Symposium 2010: new prospects for cytokinesGerd R Burmester, Peter E Lipsky, Thomas Dörner, et al.
Arthritis Research & Therapy|January 8, 2008
Cells of the synovium in rheumatoid arthritis. MacrophagesRaimund W Kinne, Bruno Stuhlmüller, Gerd-R Burmester
Arthritis Research & Therapy|April 3, 2004
Multiple functions for CD28 and cytotoxic T lymphocyte antigen-4 during different phases of T cell responses: implications for arthritis and autoimmune diseasesMonika C Brunner-Weinzierl, Holger Hoff, Gerd-R Burmester
The Journal of Rheumatology|June 6, 2008
Longlasting remissions after treatment with rituximab for autoimmune myositisEugen Feist, Thomas Dörner, Helmut Sörensen, et al.
Annals of the Rheumatic Diseases|October 15, 2020
Trajectories of COVID-19 information in the Annals of the Rheumatic Diseases: the first months of the pandemicKim Lauper, Johannes W J Bijlsma, Gerd R Burmester
Pageof 34

Showing results (41-50 of 334) with videos related to

Sort By:
Pageof 34
Journal of Autoimmunity|January 26, 2020
The etiology of rheumatoid arthritisHans Ulrich Scherer, Thomas Häupl, Gerd R Burmester
Rheumatology (Oxford, England)|February 21, 2025
Rheumatoid factors revisited in the age of biologic therapyAli Berkant Avci, Eugen Feist, Gerd R Burmester
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 22, 2023
Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What Have We Learned?Ali Berkant Avci, Eugen Feist, Gerd R Burmester
RMD Open|November 5, 2015
Biologicals in rheumatoid arthritis: current and futureAli Berkant Avci, Eugen Feist, Gerd-R Burmester
Annals of the Rheumatic Diseases|June 25, 2021
Successful BNT162b2 booster vaccinations in a patient with rheumatoid arthritis and initially negative antibody responseFredrik N Albach, Gerd R Burmester, Robert Biesen
Arthritis Research & Therapy|January 18, 2011
Kitasato Symposium 2010: new prospects for cytokinesGerd R Burmester, Peter E Lipsky, Thomas Dörner, et al.
Arthritis Research & Therapy|January 8, 2008
Cells of the synovium in rheumatoid arthritis. MacrophagesRaimund W Kinne, Bruno Stuhlmüller, Gerd-R Burmester
Arthritis Research & Therapy|April 3, 2004
Multiple functions for CD28 and cytotoxic T lymphocyte antigen-4 during different phases of T cell responses: implications for arthritis and autoimmune diseasesMonika C Brunner-Weinzierl, Holger Hoff, Gerd-R Burmester
The Journal of Rheumatology|June 6, 2008
Longlasting remissions after treatment with rituximab for autoimmune myositisEugen Feist, Thomas Dörner, Helmut Sörensen, et al.
Annals of the Rheumatic Diseases|October 15, 2020
Trajectories of COVID-19 information in the Annals of the Rheumatic Diseases: the first months of the pandemicKim Lauper, Johannes W J Bijlsma, Gerd R Burmester
Pageof 34